Q: We’re planning to get pregnant, and I wondered what you could suggest to make sure I have a healthy baby? — Donna R., Fort ...
The Pittsburgh Steelers are elevating cornerback James Pierre to the active roster. Pierre was initially on the practice squad but was elevated for the team’s game as the New York Jets to be a special ...
Verywell Health on MSN
What Drinking Hibiscus Tea Regularly Does for Heart and Digestive Health
Medically reviewed by Sohaib Imtiaz, MD Sipping hibiscus tea regularly can have a positive impact on your heart and gut health. It's known to lower blood pressure, manage cholesterol levels, boost ...
Objective Functional complete revascularisation (FCR) has been proven to be associated with superior prognosis following percutaneous coronary intervention. Whether guideline-directed medical therapy ...
Chelsea striker Joao Pedro was left in a bad way after a collision with Brazil team-mate Gabriel Martinelli. The former Brighton star, who joined the Blues for £60million over the summer, was seen ...
So welcome to the Cantor Global Healthcare Conference. I'm Pete Stavropoulos, a biotech analyst with Cantor. With us, we have Vera Therapeutics, a company I cover, and I'm pleased to introduce ...
NICE has removed a requirement in its updated guidance on chronic heart failure for GPs to seek specialist advice before prescribing a sodium-glucose cotransporter-2 (SGLT2) inhibitor. It comes after ...
The Prince and Princess of Wales were caught in a rainstorm as they visited the Natural History Museum for their first official engagement since their summer break. There was much comment on Catherine ...
School of Life Sciences, Hebei University, Baoding, Hebei 071002, China School of Life Sciences, Hebei University, Baoding, Hebei 071002, China Baoding Key Laboratory of Cancer and Aging, Hebei ...
ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are equally recommended as first-line treatment for cardiovascular and renal protection in clinical practice.
Designation supports the potential of olomorasib plus Keytruda to address unmet needs in the first-line treatment of patients with KRAS G12C-mutant non-small lung cancer with high PD-L1 expression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results